“…Our findings clearly show that, during follow-up, patients with CHD had appropriate shocks of the device in a higher percentage and earlier (on average 9.7 months earlier) than the subjects with IHD. This behavior by patients with CHD of having ICD shocks more prematurely had already been described 12 , a trend that would be clearly influenced by the substrate produced by the disease on the myocardium, since, as observed in our analysis, the population with IHD exhibits a higher proportion of factors traditionally associated with an increase in the probability of having appropriate ICD shocks (lower left ventricular ejection fraction and less use of antiarrhythmic drugs) 13 . Interestingly, the entire population with CHD and ICD implantation as sudden cardiac death secondary prevention had appropriate shocks during the first 26 months of follow-up, representing the group at highest risk for receiving therapies by the device, a behavior that had also been observed in previous series 14,15 , in which this population had twice the risk of having effective ICD discharges, in comparison with patients with heart disease of other etiologies 8 .…”